Reduced-Intensity Conditioning (RIC) with Busulfan, Fludarabine and Campath-1H Is Complicated by a High Rate of Graft Failure and Severe Viral Complications in Patients with CLL.
Johannes Schetelig(University Hospital Carl Gustav Carus), W. Siegert(University of Göttingen), Gerhard Ehninger(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Alexander Kiani(Bayreuth Medical Center), Martin Bornhaeuser(German Cancer Research Center), Christoph Roellig(University Hospital Carl Gustav Carus), Thomas Illmer(Center for Systems Biology Dresden), Johannes Mohm(University Hospital Carl Gustav Carus), Gabi Prange(University Hospital Carl Gustav Carus), Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Gabriele Geissler(Klinikum Chemnitz), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 3
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k